Structural modifications on the phenazine N, N′-dioxide-scaffold looking for new selective hypoxic cytotoxins

We have identified phenazine 5,10-dioxides as prodrugs for antitumour therapy that undergo hypoxic-selective bioreduction to form cytotoxic species. Here, we investigated some structural modifications in order to find new selective hypoxic cytotoxins and to establish the structural requirements for...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of medicinal chemistry Vol. 45; no. 11; pp. 5362 - 5369
Main Authors Lavaggi, María Laura, Nieves, Marcos, Cabrera, Mauricio, Olea-Azar, Claudio, López de Ceráin, Adela, Monge, Antonio, Cerecetto, Hugo, González, Mercedes
Format Journal Article
LanguageEnglish
Published ISSY-LES-MOULINEAUX Elsevier Masson SAS 01.11.2010
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:We have identified phenazine 5,10-dioxides as prodrugs for antitumour therapy that undergo hypoxic-selective bioreduction to form cytotoxic species. Here, we investigated some structural modifications in order to find new selective hypoxic cytotoxins and to establish the structural requirements for adequate activity. Three different chemical-series were prepared and the clonogenic survival of V79 cells on aerobic and anaerobic conditions was determined. Electrochemical- and DNA-interaction studies were done for the most relevant derivatives. The new fluoro-derivative 7-fluoro-2-aminophenazine 5,10-dioxide displayed selective toxicity towards hypoxic V79 cells having adequate hypoxic cytotoxicity ratio (HCR = 6.8) and being the most potent hypoxic cytotoxins ( P = 2.5 μM) described for this family of bioreductive agents. The reduction potential of the N-oxide moiety in this new fluoro-derivative was in the range for adequate bioreduction property. According to the fluorescence studies, the DNA-interaction mechanism was especially operative in the phenazine drugs more than in the corresponding prodrugs, phenazine dioxides. [Display omitted] 7-Fluoro-2-aminophenazine 5,10-dioxide was identified as new bioreductive agent (HCR = 6.8, P hypoxia = 2.5 μM).
ISSN:0223-5234
1768-3254
DOI:10.1016/j.ejmech.2010.08.061